November 17, 2024
Take on a more active and confident role in the PRO strategy and implementation process
Formulation of a successful PRO strategy requires an understanding of PRO instrument selection, psychometric evaluation, data capture, and interpretation to negotiate regulatory, reimbursement, and market access drug development hurdles. Judging PRO instrument quality and appropriateness can be challenging.
Enroll in this course to:
- Engage in discussions of the steps needed to successfully implement patient-reported outcomes (PRO) measurement within the drug development program to generate data to support patient-centered value messages.
- Explore the key elements to consider at each step in reviewing and selecting PRO measures and determining the need for new instruments.
- Understand the regulatory expectations for qualitative and quantitative evidence to support the quality of PRO measures and aspects to consider when interpreting meaningful change.
- Engage in interactive discussions of PRO success stories and common pitfalls to watch out for during PRO implementation in clinical trial programs.
This short course is offered in-person at the ISPOR Europe 2024 conference.
*Conference attendance is not required to attend an ISPOR Short Course. Separate registration is required for conference attendees.
LEVEL: Experienced
TRACK: Patient-Centered Research
HEOR Key Competency: 12.1 Patient-Reported Outcomes (PRO) Development, Including Psychometrics
LENGTH: 4 Hours | Course runs 1 day
FACULTY MEMBERS
Schedule:
Sunday, 17 November 2024 | Course runs 1 Day
13:00-17:00 Central European Time (CET)
Register Here
*Conference attendance is not required to attend an ISPOR Short Course. Separate registration is required for conference attendees.
Visit the ISPOR Europe 2024 Program page to view all short courses offered.